REMAP-CAP / LOVIT-COVID Vitamin C Trial

Studi estratti dal podcast di Rob Mac Sweeney

• 2023LOVIT-COVIDICU & Critical CareIn 2590 hospitalized patients with COVID-19, intravenous vitamin C did not improve organ support-free days or hospital survival versus control
• 2022LOVITICU & Critical CareIn 872 ICU patients with sepsis on vasopressors, intravenous vitamin C increased death or persistent organ dysfunction at 28 days compared with placebo.